Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Mar 29, 2023 4:31pm
162 Views
Post# 35367775

RE:RE:RE:RE:RE:RE:RE:RE:New FDA Proposed Guidance on AA

RE:RE:RE:RE:RE:RE:RE:RE:New FDA Proposed Guidance on AA

Oilminerdeluxe wrote: I hope you guys are able to have a clue about what is going on. I have given up trying to understand what is happening or not. 

 

No worries oilminer...this proposal should not apply to our current trial.  

If the FDA is truly concerned about scientific integrity & patient health (not Pharma wealth), any future changes should reflect (at least partially) that stance.  Single-arm trials are quite appropriate for those indications that have critical need (lack of other good options for a serious illness) &/or that have a scarcity of patients.  I do think there will be more reasonable recommendations made by clinical/research experts that are in line with the above.  

Having said that, we know how Big Brother & Big Pharma work, & when a proposal is made by either, that generally means changes will be made regardless of external input or independent opinion.  Just have to hope the FDA doesn't overstep its regulatory bounds & they can find an appropriate middle ground that best addresses patient needs/health.  

Generally speaking, proposed changes can become effective relatively quickly...if there are no significantly differing or adverse suggestions made by the public/outside experts, there could be a final ruling with an established effective date done in as early as ~5 months.  Anybody's guess if there will be significant enough opposition to delay such a decision.  I will give them my thoughts...

<< Previous
Bullboard Posts
Next >>